Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | RAB9A | P51151 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | LTA4H | P09960 | 4/20 | 0.60 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.60 |
| ▸ | CNR2 | P34972 | 2/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.49 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL338731 | 0.92 | LTA4H (0.60) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL1053968 | 0.88 | ADRB2 (0.62) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL13021253 | 0.87 | NPC1 (0.56) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL10821631 | 0.86 | MAPT (0.55) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL22264596 | 0.84 | NR5A1 (0.62) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL30504179 | 0.84 | NR5A1 (0.62) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL11983843 | 0.84 | LTA4H (0.56) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL4961756 | 0.84 | LTA4H (0.56) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL77484 | 0.83 | NR5A1 (0.60) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL7972017 | 0.83 | NR5A1 (0.60) | MEN1NPC1ALDH1A1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2271651-B1 | ISOTHERMAL PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-01-01 | — | — | EP | disclosed |
| EP-2346887-B1 | SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2013-12-25 | — | — | EP | disclosed |
| US-8546600-B2 | Slurry process for synthesis of bisphosphites and situ use thereof for producing bisphosphite | DOW TECHNOLOGY INVESTMENTS LLC | 2013-10-01 | — | — | US | disclosed |
| EP-2257560-B1 | SLURRY PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | UNION CARBIDE CHEM PLASTIC (US) | 2013-07-17 | — | — | EP | disclosed |
| US-8471066-B2 | Slurry process for phosphoromonochloridite synthesis | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2013-06-25 | — | — | US | disclosed |
| US-8097749-B2 | Isothermal process for phosphoromonochloridite synthesis | Union Carbide Chemical and Plastics Technology Technology | 2012-01-17 | — | — | US | disclosed |
| US-20110196166-A1 | SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE | DOW TECHNOLOGY INVESTMENTS LLC | 2011-08-11 | — | — | US | disclosed |
| US-20110021840-A1 | SLURRY PROCESS FOR PHOSPHOROMONOCHLORIDITE SYTHESIS | UNION CARBIDE CORPORATION | 2011-01-27 | — | — | US | disclosed |
| US-20090247790-A1 | ISOTHERMAL PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | UNION CARBIDE CORPORATION | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247790-A1 | ISOTHERMAL PROCESS FOR PHOSPHOROMONOCHLORIDITE SYNTHESIS | PIM3, PLCB3, PLCD1 | MEN1 1996/4885NPC1 4133/4885ALDH1A1 4149/4885 |
| US-20110196166-A1 | SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE | SOST, PLCB3, PPIP5K2 | MEN1 1290/4885NPC1 3196/4885ALDH1A1 4653/4885 |
| US-20110021840-A1 | SLURRY PROCESS FOR PHOSPHOROMONOCHLORIDITE SYTHESIS | PSPH, SPIN3, SYNGR2 | MEN1 561/4885NPC1 3610/4885ALDH1A1 4865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.